MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-30-0004070
Reichindia Pharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹9.54 Cr
▼ 10% YoY
Net profit · FY 2022
₹8.92 Cr
Net margin 93.4%
EBITDA · FY 2022
₹2.71 Cr
EBITDA margin 28.4%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹7 Cr
Issued & subscribed
Open charges
₹30.27 Lakh
Satisfied ₹5.75 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
99
Provident fund records
About Reichindia Pharma Limited
Data last updated:
Reichindia Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 August 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1995PLC021457. Its GSTIN is 36AAACR9632G1ZA (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹7 Cr. It was formerly known as Reich India Bio-Application Limited and Reich India Bio-Application Private Limited. It is led by directors Srihari Kaligithi and Tulasi Venkata Ramana Murthy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.54 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹8.92 Cr (net margin 93.4%) and EBITDA of ₹2.71 Cr (EBITDA margin 28.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The company has about 99 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Reichindia and Amoeba Education. As per MCA filings, the company has open charges of ₹30.27 Lakh and satisfied charges of ₹5.75 Cr on record. Court records list 8 cases involving the company, including 3 filed by the company and 5 filed against it; 2 cases are pending. The company has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹6.8 Cr; the latest was in March 2016. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Tulsi Intermediates Private Limited with revenue of ₹9.67 Cr.
Reichindia Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-30-0004070). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reichindia.com.
Company details
CIN U24230TG1995PLC021457
Registration Number 021457
Incorporation Date 21 August 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-30-0004070
Name history
Reichindia Pharma has undergone 2 name changes throughout its history. The company was previously known as Reich India Bio-Application Limited, and Reich India Bio-Application Private Limited. The current legal name is Reichindia Pharma Limited.
| Company Name | Status |
|---|---|
| Reichindia Pharma Limited | Current |
| Reich India Bio-Application Limited | Previous |
| Reich India Bio-Application Private Limited | Previous |
CIN history
Reichindia Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230TG1995PLC021457, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1995PLC021457 | Current |
| U24230AP1995PLC021457 | Previous |
| U24230AP1995PTC021457 | Previous |
Recognitions & Rankings of Reichindia Pharma
Contact details
Reichindia Pharma Limited's registered office is in Hyderabad, Telangana. Its website is reichindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 403 Concrete Trumphet H.No.1 – 3 – 85 85/1 86 Street No. 4 Hab, Siguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, API Manufacturers
To see the full contact details of Reichindia Pharma Limited, buy the company report.
Comprehensive company report
Reichindia Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Reichindia Pharma operates two associated brands: Reichindia and Amoeba Education. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Reich India provides pharmaceutical products, animal health care, and contract manufacturing services in Telangana. | reichindia.in | |
| Education consultancy and K-12 school services focused on school management and training. | reichindia.com |
Business activity
The main business activity of Reichindia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Reichindia Pharma Limited, buy the company report.
Financials of Reichindia Pharma Limited
FY 2024 filings availableReichindia Pharma Limited reported revenue of ₹9.54 Cr (down 10% YoY) for FY 2022.
Revenue · FY 2022
₹9.54 Cr ▼ 10%
Net profit · FY 2022
₹8.92 Cr margin 93.4%
EBITDA · FY 2022
₹2.71 Cr margin 28.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 2%
5 years · compounded
▲ 1%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.4% | ||||
| Net Profit Margin | 93.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reichindia Pharma Limited, buy the company report.
Board of directors of Reichindia Pharma Limited
Reichindia Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srihari Kaligithi | Additional Director | 02 May 2023 | 3 Years 5 Months | Current |
| Tulasi Venkata Ramana Murthy | Additional Director | 02 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Reichindia Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tulsi Intermediates Private Limited | ₹9.67 Cr (FY 2024) | 12.0% | Ahmedabad, Gujarat, India | |||
| Aditya Medi Pharma Private Limited | ₹9.55 Cr (FY 2025) | 35.0% | Hyderabad, Telangana, India | |||
| Reichindia Pharma Limitedthis company | ₹9.54 Cr (FY 2022) | ₹8.92 Cr | 93.4% | -10.0% | 99 | Hyderabad, Telangana, India |
| Truelife Pharma Private Limited | ₹9.42 Cr (FY 2025) | 35.0% | Kalol, Gujarat, India | |||
| Horster Biotek Private Limited | ₹9.25 Cr (FY 2025) | 16.0% | Indore, Madhya Pradesh, India | |||
| Esschem Private Limited | ₹9.23 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Reichindia Pharma Limited, buy the company report.
Auditor
Reichindia Pharma Limited is audited by D VENUGOPAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D VENUGOPAL & CO | FY 2021 | 005712S |
Shareholding
The shareholding of Reichindia Pharma Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2018 | FY 2017 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Reichindia Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹30.27 Lakh
Satisfied charges
₹5.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2020 | 100437969 | Hdfc Bank Limited | ₹30.27 Lakh | Open | |
| 15 Oct 2016 | 100058606 | State Bank of India | ₹52.8 Lakh | Satisfied | |
| 31 Mar 2016 | 100032357 | Others | ₹1.85 Cr | Satisfied | |
| 09 Mar 2013 | 10423658 | State Bank of India | ₹8 Lakh | Satisfied | |
| 19 Mar 2011 | 10277703 | State Bank of India | ₹75 Lakh | Satisfied |
To see the full charge records of Reichindia Pharma Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Reichindia Pharma Limited has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹6.8 Cr; the latest was in March 2016.
Total deals
11
Secondary share transfers
6
Funding rounds
5
Disclosed funding
₹6.8 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Funding round | ₹55.7 Lakh | Investors: an individual |
| Mar 2015 | Funding round | ₹97.4 Lakh | Investors: 2 individuals |
| Mar 2014 | Funding round | ₹3.03 Cr | Investors: 3 individuals |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Reichindia Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Reichindia Pharma Limited has 8 court cases on record: 3 filed by Reichindia Pharma, 5 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
3
Filed against the company
5
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| NCLT | 2 | 1 | 0 |
| NCLAT | 2 | 0 | 2 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Insolvency matter | Filed by the company against an individual | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by an individual | Disposed |
| NCLT, Hyderabad | Insolvency matter | Filed by the company | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Reichindia Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reichindia Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Reichindia Pharma Limited has a workforce of 99 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
99
Active EPFO establishments
1
Employee growth
22.22%
GST
Reichindia Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACR9632G1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reichindia Pharma Limited, buy the company report.
Recent activity
Reichindia Pharma Limited has 14 board changes on record since 1995: 8 appointments and 6 cessations. The latest: Gandavarapu Sharma ceased to be Director on 05 Nov 2024.
Ceased
Gandavarapu Sharma ceased to be Director.
AGM
Reichindia Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Reichindia Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Chidara Neelima ceased to be Director.
Ceased
Syam Sunder Chidara ceased to be Director.
Appointed
Srihari Kaligithi was appointed as Additional Director.
Appointed
Tulasi Venkata Ramana Murthy was appointed as Additional Director.
Charges
A charge registered on 31 Mar 2016 via Charge ID 100032357 with Others was fully satisfied on 16 Feb 2022.
Charges
A charge registered on 21 Feb 2009 via Charge ID 10145769 with Ap State Financial Corporation was fully satisfied on 16 Feb 2022.
Charges
A charge registered on 15 Oct 2016 via Charge ID 100058606 with State Bank Of India was fully satisfied on 15 Feb 2022.
Charges
A charge registered on 09 Mar 2013 via Charge ID 10423658 with State Bank Of India was fully satisfied on 15 Feb 2022.
Charges
A charge registered on 19 Mar 2011 via Charge ID 10277703 with State Bank Of India was fully satisfied on 15 Feb 2022.
26 earlier events are in the company report.
Frequently asked questions
Reichindia Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 August 1995 (31+ years old) and is registered under CIN U24230TG1995PLC021457.
Reichindia Pharma has 2 current directors:
- Srihari Kaligithi - Additional Director
- Tulasi Venkata Ramana Murthy - Additional Director
The latest financial statements of Reichindia Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Reichindia Pharma is 36AAACR9632G1ZA, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Reichindia Pharma is U24230TG1995PLC021457. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reichindia Pharma has 8 court cases on record: 3 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Reichindia Pharma was incorporated on 21 August 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Reichindia Pharma has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹6.8 Cr; the latest was in March 2016.
The peers of Reichindia Pharma by revenue are Tulsi Intermediates Private Limited, Aditya Medi Pharma Private Limited, Truelife Pharma Private Limited, Horster Biotek Private Limited, Esschem Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gandavarapu Sharma ceased to be Director on 05 Nov 2024. Chidara Neelima ceased to be Director on 03 May 2023. Syam Sunder Chidara ceased to be Director on 03 May 2023. Reichindia Pharma has 14 board changes on record in total.
Yes, Reichindia Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-30-0004070).